FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

Kalshi Health › FDA & drugs Closes Mar 31, 2027 · prices read 7 h ago

Embed

The odds

71%chance▲ 1

How the odds have moved

Yes: 71% on Nov 3, 71% now.

Each outcome's chance over time on Kalshi. The dots along the bottom are headlines about its subject: point at one to read it.

Every outcome

Outcome Chance Day Bid Ask Pays Contracts
Yes 71% ▲ 1 67¢ 74¢ $1.35

"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".

The news: FDA, Tozorakimab, AstraZeneca

Search ›
  • Key facts: AstraZeneca bid report; NICE access, FDA clears IMCIVREETradingView · 5 days agoTradingView Key facts: AstraZeneca bid report; NICE access, FDA clears IMCIVREE - Rhythm Pharmaceuticals (RYTM) shares rose 28% to $110.68 after a report that AstraZeneca offered about $124 per share, valuing the company at roughly $10…
  • FDA grants tentative approval to low-cost HIV shotsemafor.com · 5 days agoThe potential rollout of a more affordable injection to help prevent HIV infection lifts hopes for reduced AIDS deaths in Africa. US regulators’ approval of a cheaper HIV shot has lifted hopes in some of the world’s poorest countries…
  • AstraZeneca offers $10B to buy drugmaker RhythmThe Manila Times · 4 days agoASTRAZENECA made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter. AstraZeneca offered as much as $134 a share in the nonbinding proposal, including…
  • Pharma critic Bernie Sanders is set to hold major sway over FDA funding billSTAT · 5 days agoSTAT WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a key funding source for the Food and Drug Administration in part by empowering a major critic of…
  • AstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reportsETPharma.com · 4 days agopharma.economictimes.indiatimes.com AstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports - Published On Nov 6, 2026 at 08:38 AM IST Find this Comment Offensive? Join the community of 2M+ industry professionals. All…
  • AstraZeneca Makes USD 10 Billion Bid for Obesity Drugmaker Rhythm PharmaceuticalsMedical Dialogues · 4 days agoBengaluru: AstraZeneca made an about USD 10 billion offer to acquire obesity drugmaker Rhythm Pharmaceuticals, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. The British drugmaker offered about $124…
  • AstraZeneca Pharma India anticipates revised improvement charge noticeInvestyWise · 4 days agoAstraZeneca Pharma India Limited has provided an update on a potential demand notice for improvement charges and interest from Bengaluru authorities, with an existing provision of INR 156.1 million. AstraZeneca Pharma India anticipates…
  • AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and overPharmafile · 4 days agopharmafile | October 27, 2026 | News story | | Asthma & COPD, COPD, EMA, EU, Pharmacy, asthma The single-inhaler triple combination adds a long-acting muscarinic antagonist (LAMA) to ICS/LABA treatment. The approval follows a positive…
  • Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZenecaBioSpace · 4 days agoRhythm Pharmaceuticals’ shares ended Wednesday up 24% on rumors that AstraZeneca had made a $10 billion bid to buy the biotech, which focuses on rare neuroendocrine diseases. The Wall Street Journal reported the potential transaction…
  • FDA Recall Update: FebruaryPowder Bulk Solids · 4 days agoThere were 14 recalls in the food & beverage, pet food, and drugs sectors, a 25% decrease compared with last month. The US Food & Drug Administration (FDA) recalled 14 food and beverage, pet food, and drugs products, and updated a previous…
  • Nordic stocks in North America - AstraZeneca fell 0.5 percentMarketScreener · 4 days agoStockholm New York New York Diff... Nordic stocks in North America - AstraZeneca fell 0.5 percent Published on 11/05/2026 at 12:52 am EST Stocks mentioned in the article Latest news about Nokia Oyj Income Statement and Estimates The more…
  • FDA Upgrades Frozen Blueberry RecallPowder Bulk Solids · 4 days agoThe federal agency classified the recalled product, sold by supermarket chain Publix, as Class I, which represents the highest level of risk. On Tuesday, the US Food & Drug Administration (FDA) upgraded a growing recall on frozen…

Related markets

All fda & drugs ›

Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Progressives. Prices read from the venues 4 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.

Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Progressives, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Progressives index; prices of stocks, rates and coins from 4Progressives Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions